Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Murad M. Melhem"'
Autor:
Jessica Perrin, Frank Wippich, Valeriia Sherina, Dmytro Dvornikov, Katharina Lupar, Murad M. Melhem, Patrick Hanafin, Jeremy Waight, Jong Yu, Sapna Yadavilli, Daniel Poeckel, Giovanna Bergamini
Publikováno v:
Cancer Research. 83:6647-6647
The ability to more faithfully mimic the tumor microenvironment (TME) of cancer patients offers a wide range of possibilities for non-clinical evaluation of anti-cancer therapeutics, including guidance for patient selection, dose, and combinations. W
Autor:
Samineni D; Genentech, Inc., South San Francisco, California, USA., Venkatakrishnan K; EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts, USA., Othman AA; Gilead Sciences, Inc., Foster City, California, USA., Pithavala YK; Pfizer, San Diego, California, USA., Poondru S; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA., Patel C; Bayer, Cambridge, Massachusetts, USA., Vaddady P; Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Ankrom W; Blueprint Medicines Inc, Cambridge, Massachusetts, USA., Ramanujan S; Genentech, Inc., South San Francisco, California, USA., Budha N; BeiGene USA Inc., San Mateo, California, USA., Wu M; Genentech, Inc., South San Francisco, California, USA., Haddish-Berhane N; Johnson and Johnson Innovative Medicine, Spring House, Pennsylvania, USA., Fritsch H; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany., Hussain A; Merck & Co. Inc., Lansdale, Pennsylvania, USA., Kanodia J; Xencor, Pasadena, California, USA., Li M; Bristol Myers Squibb, Princeton, New Jersey, USA., Li M; Sanofi, Bridgewater, New Jersey, USA., Melhem M; GlaxoSmithKline, Waltham, Massachusetts, USA., Parikh A; AbbVie, South San Francisco, California, USA., Upreti VV; Amgen Inc., South San Francisco, California, USA., Gupta N; Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep; Vol. 116 (3), pp. 531-545. Date of Electronic Publication: 2024 May 16.
Autor:
Kuchimanchi M; Clinical Pharmacology Modeling and Simulation, GSK, Waltham, Massachusetts, USA., Dabrowski C; Global Safety Oncology, GSK, Collegeville, Pennsylvania, USA., Lu S; Clinical Pharmacology Modeling and Simulation, GSK, Waltham, Massachusetts, USA., Melhem M; Clinical Pharmacology Modeling and Simulation, GSK, Waltham, Massachusetts, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Jul; Vol. 89 (7), pp. 2272-2282. Date of Electronic Publication: 2023 Mar 20.
Autor:
Austin D; GSK, Brentford, UK., Melhem M; GSK, Waltham, Massachusetts, USA., Gandhi Y; GSK, Collegeville, Pennsylvania, USA., Lu S; GSK, Waltham, Massachusetts, USA.; Eyepoint Pharmaceuticals, Watertown, Massachusetts, USA., Visser S; GSK, Collegeville, Pennsylvania, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Jan; Vol. 12 (1), pp. 87-94. Date of Electronic Publication: 2022 Nov 16.
Autor:
Melhem M; GlaxoSmithKline, Waltham, MA, USA., Hanze E; qPharmetra, Cary, NC, USA., Lu S; GlaxoSmithKline, Waltham, MA, USA.; Scholar Rock, Cambridge, MA, USA., Alskär O; qPharmetra, Cary, NC, USA., Visser S; GlaxoSmithKline, Collegeville, PA, USA., Gandhi Y; GlaxoSmithKline, Collegeville, PA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Sep; Vol. 88 (9), pp. 4142-4154. Date of Electronic Publication: 2022 Apr 28.
Autor:
Harrold J; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA., Gisleskog PO; SGS Exprimo NV, Mechelen, Belgium., Perez-Ruixo JJ; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA., Delor I; SGS Exprimo NV, Mechelen, Belgium., Chow A; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA., Jacqmin P; SGS Exprimo NV, Mechelen, Belgium., Melhem M; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2020 Jul; Vol. 13 (4), pp. 807-817. Date of Electronic Publication: 2020 Apr 06.
Autor:
Harrold J; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA.; Seattle Genetics, Bothell Washington, Massachusetts, USA., Gisleskog PO; SGS Exprimo NV, Mechelen, Belgium.; POG Pharmacometrics, Hampshire, UK., Delor I; SGS Exprimo NV, Mechelen, Belgium., Jacqmin P; SGS Exprimo NV, Mechelen, Belgium., Perez-Ruixo JJ; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA.; Janssen Research & Development, Valencia, Spain., Narayanan A; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA., Doshi S; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA., Chow A; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA.; Rigel Pharmaceuticals Inc., South San Francisco, California, USA., Yang BB; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA., Melhem M; Department of Clinical Pharmacology, Modeling and Simulation, Amgen Inc., Thousand Oaks, California, USA. murad_melhem@vrtx.com.; Vertex Pharmaceuticals, Boston, Massachusetts, USA. murad_melhem@vrtx.com.
Publikováno v:
Pharmaceutical research [Pharm Res] 2020 May 21; Vol. 37 (6), pp. 102. Date of Electronic Publication: 2020 May 21.
Autor:
Chen P; Amgen Inc., Thousand Oaks, CA, USA., Sohn W; Amgen Inc., Thousand Oaks, CA, USA., Narayanan A; Amgen Inc., Thousand Oaks, CA, USA., Gisleskog PO; SGS Exprimo, London, UK., Melhem M; Amgen Inc., Thousand Oaks, CA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Jun; Vol. 85 (6), pp. 1312-1325. Date of Electronic Publication: 2019 Apr 25.
Autor:
Clements JD; Clinical Pharmacology and Modeling & Simulation, Amgen Inc., Thousand Oaks, California, USA., Perez Ruixo JJ; Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, Beerse, Belgium., Gibbs JP; Clinical Pharmacology and Pharmacometrics, AbbVie, North Chicago, Illinois, USA., Doshi S; Clinical Pharmacology and Modeling & Simulation, Amgen Inc., Thousand Oaks, California, USA., Perez Ruixo C; Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, Beerse, Belgium., Melhem M; Clinical Pharmacology, Vertex Pharmaceuticals, Boston, Massachusetts, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2018 Nov; Vol. 7 (11), pp. 771-779. Date of Electronic Publication: 2018 Oct 15.
Autor:
Radivojevic A; Pharmacometrics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. andrijana.radivojevic@intigrowth.com., Corrigan B; Pfizer Global Research, Groton, CT, USA., Downie N; Bayer AG, Berlin, Germany., Fox R; AstraZeneca, Waltham, MA, USA., Fiedler-Kelly J; Cognigen Corporation, Buffalo, NY, USA., Liu H; AstraZeneca, Waltham, MA, USA., Melhem M; Amgen, Thousand Oaks, CA, USA., Radke D; Eli Lilly and Company, Indianapolis, IN, USA., Schaefer P; VCA-Plus, Raleigh, NC, USA., Su J; Merck & Co., Kenilworth, NJ, USA., Swat MJ; Simcyp (A Certara Company), Sheffield, UK., Teuscher NS; Certara, Princeton, NJ, USA., Thanneer N; Bristol-Myers Squibb, Princeton, NJ, USA., Zong A; Janssen, Horsham, PA, USA., Wilkins JJ; Occams, Amstelveen, The Netherlands.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2018 Oct; Vol. 45 (5), pp. 659-661. Date of Electronic Publication: 2018 Jul 25.